Hospices Civils de Lyon: Lung Neoplasms trials
The registry lists 15 Lung Neoplasms studies with Hospices Civils de Lyon as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Food-related Quality of Life in Patients With CancerNot yet recruitingNCT07437326
- Mobile Lung Cancer ScreeningRecruitingNCT07015151
- Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research PathwayRecruitingNCT06781905
- Lung Cancer Screening Implementation Among Employees at Lyon HospitalRecruitingNCT05452200Not applicable
- Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)RecruitingNCT05267041Not applicable
- CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung CancerRecruitingNCT02764606
- Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck CancerCompletedNCT05523583
- Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)CompletedNCT05472532Not applicable
- Assessment of Histologic Prognostic Factors in Peritoneal Malignant MesotheliomaStatus unknownNCT05193006
- Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)TerminatedNCT04957602
- Initiative in LYon for Lung cAncer Screening Development - Prevalence StudyCompletedNCT04240418
- Benefit Evaluation of Foot Reflexology in OncologyCompletedNCT03508180Not applicable
- Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)CompletedNCT02810262
- IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00300586Phase 3
- Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00198367Phase 2